1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Worst Reps??

Discussion in 'Middlebrook Pharmaceuticals' started by Anonymous, Aug 9, 2010 at 6:28 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    I worked for Middlebrook at the launch of Moxatag-now I work for another pharma co. I had a provider tell me last week that a Moxatag rep was in to see him. He said "thank god you got away from that product" Like I didn't know that-anyway, they must still have some reps or else they sold the drug off to someone else. Don't know that the deal is..........
     
  2. Anonymous

    Anonymous Guest

    this didn't happen. when were you fired?